Applications of human hematopoietic stem cells isolated and expanded from different tissues in regenerative medicine

Regenerative Medicine

Volumn 8, Issue 6, 2013, Pages 783-795

  Tripura, Chaturvedula ^a   Pande, Gopal ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

biomaterials; ex vivo expansion; hematopoietic stem cell niche; leukemia; tissue scaffolds; transplantation

Indexed keywords

BIOMATERIAL; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CYCLOSPORIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; BRAIN ISCHEMIA; CELL ISOLATION; CEREBRAL PALSY; CORD BLOOD STEM CELL TRANSPLANTATION; CRITICAL LIMB ISCHEMIA; CULTURE MEDIUM; CULTURE TECHNIQUE; DNA MODIFICATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FEEDER CELL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL EXPANSION; STEM CELL MOBILIZATION; STEM CELL NICHE; UMBILICAL CORD BLOOD; UNSPECIFIED SIDE EFFECT;

CELL PROLIFERATION; CELL SEPARATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; ORGAN SPECIFICITY; REGENERATIVE MEDICINE;

EID: 84886565780     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.75     Document Type: Review

References (85)

1. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New Engl. J. Med. 257(11), 491-496 (1957
2. Passweg JR, Halter J, Bucher C et al. Hematopoietic stem cell transplantation: A review and recommendations for follow-up care for the general practitioner. Bone Marrow Transplant. 47(7), 906-923 (2012
3. Ledran MH, Krassowska A, Armstrong L et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3(1), 85-98 (2008
4. Choi KD, Yu J, Smuga, Otto K et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27(3), 559-567 (2009
5. Mimeault M, Hauke R, Batra S. Stem cells: A revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin. Pharmacol. Ther. 82(3), 252-264 (2007
6. Namiri M, Baharvand H, Aghdami N. Methods for isolation of bone marrow stem cells: Comparative analysis. Cell 12(4), 439-446 (2011
7. Craiu A, Scadden D. Flow electroporation with pulsed electric fields for purging tumor cells. In: Electroporation Protocols. Springer, NJ, USA, 301-310 (2008
8. Yang H, Robinson SN, Nieto Y et al. Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma. Cancer Res. 71(14), 5040-5049 (2011
9. Huang H, Chen Y, Chen W, Wu Y. Purging efficacy of ZnPcH1-based photodynamic therapy on chronic myeloid leukemia bone marrow. Int.J. Lab. Hematol. 33(5), 477-482 (2011
10. Bartee E, Chan WM, Moreb JS, Cogle CR, McFadden G. Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus. Biol. Blood Marrow Transplant. 18(10), 1540-1551 (2012
11. Mackie AR, Losordo DW. CD34-positive stem cells: In the treatment of heart and vascular disease in human beings. Tex. Heart Inst. J. 38(5), 474-485 (2011
12. Rettig MP, Ansstas G, Dipersio JF Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4. Leukemia 26(1), 34-53 (2012
13. Barriga F, Ramírez P, Wietstruck A, Rojas N. Hematopoietic stem cell transplantation: Clinical use and perspectives. Biol. Res. 45(3), 307-316 (2012
14. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-Versus-host disease. Lancet 373(9674), 1550-1561 (2009
15. Booth C, Veys P. T cell depletion in paediatric stem cell transplantation. Clin. Exp. Immunol. 172(2), 139-147 (2013
16. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119(1), e296-e300 (2007
17. Lapierre V, Pellegrini N, Bardey I et al. Cord blood volume reduction using an automated system (Sepax) vs. a semi-Automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: A comparative study. Cytotherapy 9(2), 165-169 (2007
18. Grigoriadis AE, Kennedy M, Bozec A et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115(14), 2769-2776 (2010
19. Lapillonne H, Kobari L, Mazurier C et al. Red blood cell generation from human induced pluripotent stem cells: Perspectives for transfusion medicine. Haematologica 95(10), 1651-1659 (2010
20. Dias J, Gumenyuk M, Kang H et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 20(9), 1639-1647 (2011
21. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 112(12), 4475-4484 (2008
22. Takayama N, Nishikii H, Usui J et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111(11), 5298-5306 (2008
23. Kennedy M, Awong G, Sturgeon CM et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2(6), 1722-1735 (2012
24. Ye Z, Zhan H, Mali P et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114(27), 5473-5480 (2009
25. Raya Á, Rodríguez-Pizà I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460(7251), 53-59 (2009
26. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl Acad. Sci. USA 106(24), 9826-9830 (2009
27. Kröger N, Holler E, Kobbe G et al. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: A prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 114(26), 5264-5270 (2009
28. Gill S, Porter DL. Reduced-intensity hematopoietic stem cell transplants for malignancies: Harnessing the graft-Versus-Tumor effect. Annu. Rev. Med. 64, 101-117 (2013
29. Marek-Trzonkowska N, Mysliwec M, Siebert J, Trzonkowski P. Clinical application of regulatory T cells in type 1 diabetes. Pediatr. Diabetes 14(5), 322-3332 (2013
30. Dahlberg A, Delaney C, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117(23), 6083-6090 (2011
31. Peerani R, Zandstra PW. Enabling stem cell therapies through synthetic stem cell-niche engineering. J. Clin. Invest. 120(1), 60-70 (2010
32. Wasnik S, Tiwari A, Kirkland M, Pande G. Osteohematopoietic stem cell niches in bone marrow. Int. Rev. Cell Mol. Biol. 298, 95-133 (2012
33. Lu J, Pompili VJ, Das H. Hematopoietic stem cells: Ex vivo expansion and therapeutic potential for myocardial ischemia. Stem Cells Cloning 3, 57-68 (2010
34. Spanholtz J, Preijers F, Tordoir M et al. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process. PLoS ONE 6(6), e20740 (2011
35. Panuganti S, Schlinker AC, Lindholm PF, Papoutsakis ET, Miller WM. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: Toward large-scale platelet production. Tissue Eng. Part A 19(7-8), 998-1014 (2013
36. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 133(5), 775-787 (2008
37. Safinia N, Leech J, Hernandez-Fuentes M, Lechler R, Lombardi G. Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin. Exp. Immunol. 172(2), 158-168 (2013
38. Rizo A, Dontje B, Vellenga E, de Haan G, Schuringa JJLong-Term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1. Blood 111(5), 2621-2630 (2008
39. Aguila JR, Liao W, Yang J et al. SALL4 is a robust stimulator for the expansion of hematopoietic stem cells. Blood 118(3), 576-585 (2011
40. Zhang CC, Kaba M, Iizuka S, Huynh H, Lodish HF. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111(7), 3415-3423 (2008
41. Himburg HA, Muramoto GG, Daher P et al. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat. Med. 16(4), 475-482 (2010
42. De Lima M, McMannis J, Gee A et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: A Phase I/II clinical trial. Bone Marrow Transplant. 41(9), 771-778 (2008
43. Nishino T, Wang C, Mochizuki-Kashio M, Osawa M, Nakauchi H, Iwama A. Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase. PLoS ONE 6(9), e24298 (2011
44. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113(22), 5444-5455 (2009
45. Boitano AE, Wang J, Romeo R et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329(5997), 1345-1348 (2010
46. Kelly SS, Sola CBS, De Lima M, Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant. 44(10), 673-681 (2009
47. Corselli M, Chin CJ, Parekh C et al. Perivascular support of human hematopoietic stem/progenitor cells. Blood 121(15), 2891-2901 (2013
48. Yu X, Miao J, Xia W, Gu ZJ. Preferential expansion of umbilical cord blood-Derived CD34-positive cells on human leukemia inhibitory factor transgenic feeder cells cultured on regenerated silk fibroin film. J. Biomed. Mater. Res. B Appl. Biomater. 101(6), 964-971 (2013
49. Holst J, Watson S, Lord MS et al. Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat. Biotechnol. 28(10), 1123-1128 (2010
50. Chen LY, Chang Y, Shiao JS et al. Effect of the surface density of nanosegments immobilized on culture dishes on ex vivo expansion of hematopoietic stem and progenitor cells from umbilical cord blood. Acta Biomater. 8(5), 1749-1758 (2012
51. Prewitz M, Seib FP, Pompe T, Werner C. Polymeric biomaterials for stem cell bioengineering. Macromol. Rapid Commun. 33(17), 1420-1431 (2012
52. Tiwari A, Tursky ML, Mushahary D et al. Ex vivo expansion of haematopoietic stem/ progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line. J. Tissue Eng. Regen. Med. doi:10.1002/term.1479 (2012) (Epub ahead of print
53. Prewitz MC, Seib FP, von Bonin M et al. Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat. Methods 10(8), 788-794 (2013
54. Franke K, Pompe T, Bornhäuser M, Werner C. Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells. Biomaterials 28(5), 836-843 (2007
55. Jiang XS, Chai C, Zhang Y, Zhuo RX, Mao HQ, Leong KW. Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells. Biomaterials 27(13), 2723-2732 (2006
56. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16(2), 232-236 (2010
57. Chua KN, Chai C, Lee PC et al. Surface-Aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials 27(36), 6043-6051 (2006
58. Chua KN, Chai C, Lee PC, Ramakrishna S, Leong KW, Mao HQ. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/ progenitor cells. Exp. Hematol. 35(5), 771-781 (2007
59. Nichols JE, Cortiella J, Lee J et al. In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials 30(6), 1071-1079 (2009
60. Tan J, Liu T, Hou L et al. Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche. Cytotechnology 62(5), 439-448 (2010
61. Ferreira MS, Jahnen-Dechent W, Labude N et al. Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support. Biomaterials 33(29), 6987-6997 (2012
62. Leisten I, Kramann R, Ventura Ferreira MS et al. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 33(6), 1736-1747 (2012
63. Sharma MB, Limaye LS, Kale VP. Mimicking the functional hematopoietic stem cell niche in vitro: Recapitulation of marrow physiology by hydrogel-based three-Dimensional cultures of mesenchymal stromal cells. Haematologica 97(5), 651-660 (2012
64. Yuan Y, Sin WY, Xue B et al. Novel alginate three-Dimensional static and rotating culture systems for effective ex vivo amplification of human cord blood hematopoietic stem cells and in vivo functional analysis of amplified cells in NOD/SCID mice. Transfusion 53(9), 2001-2011 (2013
65. Cho CH, Eliason JF, Matthew HW. Application of porous glycosaminoglycan-based scaffolds for expansion of human cord blood stem cells in perfusion culture. J. Biomed. Mater. Res. A 86(1), 98-107 (2008
66. Di Maggio N, Piccinini E, Jaworski M, Trumpp A, Wendt DJ, Martin I. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 32(2), 321-329 (2011
67. Mortera-Blanco T, Mantalaris A, Bismarck A, Aqel N, Panoskaltsis N. Long-Term cytokine-free expansion of cord blood mononuclear cells in three-Dimensional scaffolds. Biomaterials 32(35), 9263-9270 (2011
68. Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST. Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: The long road to tolerance. Clin. Pharmacol. Ther. 93(1), 36-45 (2013
69. Dander E, Balduzzi A, Zappa G et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-Versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 88(11), 1261-1272 (2009
70. Al-Adra DP, Anderson CC. Toward minimal conditioning protocols for allogeneic chimerism in tolerance resistant recipients. Chimerism 4(1), 23-25 (2013
71. Kawamoto A, Katayama M, Handa N et al. Intramuscular transplantation of G-CSF-mobilized CD34+ cells in patients with critical limb ischemia: A Phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27(11), 2857-2864 (2009
72. Tendera M, Wojakowski W, Ruzyllo W et al. Intracoronary infusion of bone marrow-Derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre myocardial regeneration by intracoronary infusion of selected population of stem cells in acute myocardial infarction (REGENT) trial. Eur. Heart J. 30(11), 1313-1321 (2009
73. Losordo DW, Schatz RA, White CJ et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A Phase I/IIa double-blind, randomized controlled trial. Circulation 115(25), 3165-3172 (2007
74. Pagliari S, Romanazzo S, Mosqueira D, Pinto-Do ÓP, Aoyagi T, Forte G. Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair. Curr. Med. Chem. 20(28), 3429-3447 (2013
75. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant. 37(5), 439-449 (2006
76. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. 8(7), 368-376 (2002
77. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: Results of a phase 1 trial using the AastromReplicell System. Blood 101(12), 5061-5067 (2003
78. Daikeler T, Hugle T, Farge D et al. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant. 44(1), 27-33 (2009
79. Bertolini F, Battaglia M, Pedrazzoli P et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89(8), 2679-2688 (1997
80. Rubnitz J, Inaba H, Ribeiro R, Pounds S, Pui C, Leung W. Pilot study of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. Proceedings of ASCO Annual Meeting. Orlando, FL, USA, 29 May-2 June 2009 (Abstract 10034
81. Walter DH, Krankenberg H, Balzer JO et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: A randomized-start, placebo-controlled pilot trial (PROVASA). Circ. Cardiovasc. Interv. 4(1), 26-37 (2011
82. Tripura C, Khan A, Pande G. Cell based therapy for chronic liver disease: Role of fetal liver cells in restoration of the liver cell functions. In: Liver Regeneration. Baptista PM (Ed.). InTech, Croatia (2012
83. Garg V, Garg H, Khan A et al. Granulocyte colony-stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142(3), 505-512.e1 (2012
84. Pai M, Zacharoulis D, Milicevic MN et al. Autologous infusion of expanded mobilized adult bone marrow-Derived CD34+; cells into patients with alcoholic liver cirrhosis. Am. J. Gastroenterol. 103(8), 1952-1958 (2008
85. Ilic D, Miere C, Lazic E. Umbilical cord blood stem cells: Clinical trials in non-hematological disorders. Br. Med. Bull. 102(1), 43-57 (2012)